drugset / Trial / NCT01533155

Study in Healthy Volunteers to Investigate the Effects of Quinidine on the Pharmacokinetics of NKTR-118

NCT01533155

Phase 1 Completed 214 enrolled AstraZeneca
RandomizedCrossoverDouble-blindBasic science

Summary

Study in healthy volunteers to investigate the effects of Quinidine on the Pharmacokinetics of NKTR-118

Timeline

Start
2012-03
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nektar 118 Unknown 25 mg Oral
Comparator Quinidine Small molecule 200 mg Oral
Comparator Morphine Other / unclassified 10 mg/ml Intravenous

Indications